Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
15.91
-0.09 (-0.56%)
Aug 14, 2026, 3:00 PM CST
Shandong Buchang Pharmaceuticals Company Description
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicines in China and internationally.
It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes.
The company was founded in 1993 and is based in Heze, China.
Shandong Buchang Pharmaceuticals Co., Ltd.
| Country | China |
| Founded | 1993 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 7,237 |
| CEO | Chao Zhao |
Contact Details
Address: No. 369 Zhonghua West Road Heze, 274000 China | |
| Phone | 86 53 0529 9167 |
| Website | buchang.com |
Stock Details
| Ticker Symbol | 603858 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002FV6 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Chao Zhao | President |
| Yi Min Wang | Executive Vice President and Vice Chairman |
| Xiaogang Zhao | Chief Financial Officer |
| Ren Hui Xue | Vice President of Marketing and Director |
| Xin Wang | Director and Secretary |
| Dr. Zhao Buchang M.D. | Founder |
| Kai Cheng | Accounting Supervisor |
| Wei Jun Li | Vice President of Administration and Human Resources |
| Haiqin Wu | Chairman of the Academic Committee |
| Wei Zhao | Vice President of Procument |